Interleukin-6 and tumor necrosis factor-α as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide

被引:6
作者
Boffa, Giovanni M. [1 ]
Zaninotto, Martina [2 ]
Sartor, Riccardo
Mion, Monica [2 ]
Berton, Alessandra
Pasqualetto, Cristina
Razzolini, Renato
Plebani, Mario [2 ]
机构
[1] Univ Padua, Dept Cardiol, Cardiol Policlin, I-35128 Padua, Italy
[2] Univ Padua, Dept Lab Med, I-35128 Padua, Italy
关键词
B-type natriuretic peptide; heart failure; interleukin-6; prognosis; tumor necrosis factor-alpha; LEFT-VENTRICULAR DYSFUNCTION; VAL-HEFT; CYTOKINES; MORTALITY; PREDICTORS; ACTIVATION; BIOMARKERS; MORBIDITY; DISEASE; STATE;
D O I
10.2459/JCM.0b013e32832ce8e2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The reliability of interieukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) as biochemical markers of heart failure in comparison to B-type natriuretic peptide (BNP) has not been investigated in depth. Aim To compare the correlations between IL-6, TNF, BNP plasma concentrations and some clinical and instrumental variables and their prognostic value in heart failure patients. Methods In 79 patients with heart failure, the correlations between IL-6, TNF and BNP plasma concentrations and a series of 18 variables were studied. Outcome events were death from any cause and combined death and heart transplantation. Results At univariate analysis, BNP and IL-6 plasma concentrations correlated with each other (r = 0.4828; P<0.0001), with New York Heart Association class, fluid retention, left ventricular ejection fraction, mean right atrial pressure, mean pulmonary pressure and cardiac index. All these correlations were stronger with BNP. TNF plasma concentration correlated only with New York Heart Association class and left ventricular ejection fraction. During follow-up, 1-32 months, 14 patients died and nine underwent heart transplantation. At univariate analysis, both BNP and IL-6 plasma concentrations were predictors of death and heart transplantation, but only BNP was a predictor of death; however, only creatinine plasma level was an independent predictor of prognosis. Conclusion IL-6 and TNF are less reliable biochemical markers than BNP in heart failure patients. J Cardiovasc Med 10:758-764 (C) 2009 Italian Federation of Cardiology.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 30 条
[11]   Strategies for developing biomarkers of heart failure [J].
Jortani, SA ;
Prabhu, SD ;
Valdes, R .
CLINICAL CHEMISTRY, 2004, 50 (02) :265-278
[12]   Do cytokines enable risk stratification to be improved in NYHA functional class III patients?: Comparison with other potential predictors of prognosis [J].
Kell, R ;
Haunstetter, A ;
Dengler, TJ ;
Zugck, C ;
Kübler, W ;
Haass, M .
EUROPEAN HEART JOURNAL, 2002, 23 (01) :70-78
[13]  
Koller-Strametz J, 1998, J HEART LUNG TRANSPL, V17, P356
[14]   Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure [J].
Krüger, S ;
Graf, J ;
Kunz, D ;
Stickel, T ;
Hanrath, P ;
Janssens, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) :718-722
[15]   The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT [J].
Latini, R ;
Masson, S ;
Anand, I ;
Salio, M ;
Hester, A ;
Judd, D ;
Barlera, S ;
Maggioni, AP ;
Tognoni, G ;
Cohn, JN .
EUROPEAN HEART JOURNAL, 2004, 25 (04) :292-299
[16]   The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure [J].
Lee, SC ;
Stevens, TL ;
Sandberg, SM ;
Heublein, DM ;
Nelson, SM ;
Jougasaki, M ;
Redfield, MM ;
Burnett, JC .
JOURNAL OF CARDIAC FAILURE, 2002, 8 (03) :149-154
[17]   Relationship between interleukin-6 production in the lungs and pulmonary vascular resistance in patients with congestive heart failure [J].
Mabuchi, N ;
Tsutamoto, T ;
Wada, A ;
Ohnishi, M ;
Maeda, K ;
Hayashi, M ;
Kinoshita, M .
CHEST, 2002, 121 (04) :1195-1202
[18]   Circulating interleukin-6 in severe heart failure [J].
MacGowan, GA ;
Mann, DL ;
Kormos, RL ;
Feldman, AM ;
Murali, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (08) :1128-&
[19]   High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure [J].
Maeda, K ;
Tsutamoto, T ;
Wada, A ;
Mabuchi, N ;
Hayashi, M ;
Tsutsui, T ;
Ohnishi, M ;
Sawaki, M ;
Fujii, M ;
Matsumoto, T ;
Kinoshita, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1587-1593
[20]   Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction [J].
Maeda, K ;
Tsutamoto, T ;
Wada, A ;
Hisanaga, T ;
Kinoshita, M .
AMERICAN HEART JOURNAL, 1998, 135 (05) :825-832